Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
10-2011 | 07-2011 | 04-2011 | 01-2011 | 10-2010 | |
Sales | 449 | 450 | 87 | 17 | 311 |
Cost of Goods | 1 | 4 | 25 | 5 | 7 |
Gross Profit | 448 | 447 | 62 | 12 | 304 |
Operating Expenses | 1,456 | 1,658 | 1,375 | 1,543 | 1,438 |
Operating Income | -1,007 | -1,208 | -1,288 | -1,526 | -1,127 |
Other Income | -1,785 | 34 | 1 | 0 | 0 |
Pre-tax Income | -2,791 | -1,174 | -1,287 | -1,526 | -1,127 |
Income Tax | N/A | 600 | N/A | N/A | N/A |
Net Income Continuous | -2,791 | -1,774 | -1,287 | -1,526 | -1,127 |
Net Income | $-2,791 | $-1,774 | $-1,287 | $-1,526 | $-1,127 |
EPS Basic Total Ops | -0.25 | -0.25 | -0.25 | -0.25 | N/A |
EPS Basic Continuous Ops | -0.41 | -0.26 | -0.19 | -0.24 | -0.18 |
EPS Diluted Total Ops | -0.25 | -0.25 | -0.25 | -0.25 | N/A |
EPS Diluted Continuous Ops | -0.41 | -0.26 | -0.19 | -0.24 | -0.18 |
EBITDA(a) | $-1,005 | $-1,206 | $-1,286 | $-1,524 | $-1,125 |